Search Results - "Harrela, M"

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3 by Harrela, M, Koistinen, H, Kaprio, J, Lehtovirta, M, Tuomilehto, J, Eriksson, J, Toivanen, L, Koskenvuo, M, Leinonen, P, Koistinen, R, Seppälä, M

“…We assessed the magnitude of the genetic component in the variation of circulating levels of insulin-like growth factors I and II (IGF-I and IGF-II), and their…”
Get full text

High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men by Harrela, M, Qiao, Q, Koistinen, R, Tuomilehto, J, Nissinen, A, Seppälä, M, Leinonen, P

“…Insulin-like growth factor binding protein-1 (IGFBP-1) has been implicated in the development of cardiovascular disease, but it is not known whether IGFBP-1 is…”
Get more information

Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men by Harrela, M, Koistinen, R, Tuomilehto, J, Nissinen, A, Seppälä, M

“…Serum insulin-like growth factor-binding protein-1 (IGFBP-1) is regulated by insulin and has been suggested to be a marker of the insulin resistance syndrome…”
Get more information

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer by Ray‐Coquard, Isabelle, Cibula, David, Mirza, Mansoor R., Reuss, Alexander, Ricci, Caterina, Colombo, Nicoletta, Koch, Horst, Goffin, Frédéric, González‐Martin, Antonio, Ottevanger, Petronella B., Baumann, Klaus, Bjørge, Line, Lesoin, Anne, Burges, Alexander, Rosenberg, Per, Gropp‐Meier, Martina, Harrela, Maija, Harter, Philipp, Frenel, Jean‐Sébastien, Minarik, Tomas, Pisano, Carmela, Hasenburg, Annette, Merger, Michael, Bois, Andreas

“…AGO‐OVAR 12 investigated the effect of adding the oral triple angiokinase inhibitor nintedanib to standard front‐line chemotherapy for advanced ovarian cancer…”
Get full text

PO-0714: Toxicity and Clinical Outcome of IMRT versus Conventional Radiation Therapy for Endometrial Cancer by Vaalavirta, L., Larjavaara, S., Arponen-Esteves, P., Leminen, A., Collan, J., Harrela, M., Kouri, M., Tenhunen, M., Joensuu, H.

Get full text

Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men by Kalme, Tarja, Seppälä, Markku, Qiao, Qing, Koistinen, Riitta, Nissinen, Aulikki, Harrela, Maija, Loukovaara, Mikko, Leinonen, Pekka, Tuomilehto, Jaakko

“…Two binding proteins, SHBG and IGF-binding protein-1 (IGFBP-1), are both down-regulated by insulin and therefore could serve as potential indicators of the…”
Get full text

Significance of meconium staining of the amniotic fluid by Kariniemi, V, Harrela, M

“…The study was conducted to determine the significance of meconium staining and more specifically its association with fetal heart rate patterns. Five hundred…”
Get more information

Puerperal anuria by HARRELA, E M

Get more information